MK-8353
| CAS No. | 1184173-73-6 | Cat. No. | BCP23615 |
| Name | MK-8353 | ||
| Synonyms | SCH900353; SCH-900353; SCH 900353; MK 8353; MK8353; | ||
| Formula | C37H41N9O3S | M. Wt | 691.85 |
| Description | MK-8353 is a potent and orally active ERK1/2 inhibitor and anticancer drug candidate currently being developed by Schering-Plough. MK-8353 exhibited comparable potency with SCH772984 across various preclinical cancer models. | ||
| Pathways | MAPK Pathway | ||
| Targets | MEK/ERK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.